Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 8 results

Author Title Type [ Year

]

Filters: Author is Karita, E [Clear All Filters]

2007

Jaoko, W., Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., et al.. (2007). Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html

2008

Stevens, W., Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., et al.. (2008). Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials. PLoS ONE, 3, e2043. presented at the 04/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18446196

Kamali, A., Karita, E., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., et al.. (2008). A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials. In AIDS Vaccine 2008 Conference. presented at the 13/10/2008, Cape Town, South Africa. Retrieved from http://www.vaccineenterprise.org/conference_archive/2008/index.html

2010

Jaoko, W., Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., et al.. (2010). Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa. PLoS ONE, 5, e12873. presented at the 09/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20877623

Spentzou, A., Bergin, P., Gill, D., Cheeseman, H., Ashraf, A., Kaltsidis, H., et al.. (2010). Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of Human Immunodeficiency Virus-1 Vaccine Candidates. J Infect Dis, 201, 720-729. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20132004

2014

Hayes, P., Fernandez, N., Omosa-Manyonyi, G., Mpendo, J., Karita, E., Ruzagira, E., et al.. (2014). Assessment of Viral Inhibition Activity in Low Seroprevalent Adenovirus-35 Vectored HIV Vaccines +/- Adjuvanted Protein or Electroporated DNA. In HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P). presented at the 24/09/2014, Cape Town, SA. Retrieved from http://hivr4p.org/

Karita, E., Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., et al.. (2014). Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers. In HIVR4P (HIV Research for Prevention). presented at the 28/10/2014, Cape Town, South Africa. Retrieved from http://hivr4p.org/

Mutua, G., Mutengu, L., Mpendo, J., Kilembe, W., Omosa, G., Ruzagirwa, E., et al.. (2014). Major Negative Social Impacts are Rare in Phase 1 HIV Vaccine Trials in Africa. In HIV Research for Prevention 2014: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P). presented at the 28/10/2014, Cape Town, SA. Retrieved from http://hivr4p.org/